The appeal was made following the department's investigation into a report by the Hospital Authority concerning the product.
A 21-year-old woman was admitted to Queen Elizabeth Hospital on May 27 and was found to have deranged renal function and a high level of bilirubin (a pigment produced when the liver processes waste products). It was reported that she had consumed the product concerned for skin problem before the onset of symptoms. She is now in stable condition.
A spokesman for the department said that a sample of the product taken to the Government Laboratory for testing was found to have contained western drug ingredients of rifampicin.
Rifampicin is an antibiotic used in combination with other drugs for treating tuberculosis. It can cause stomach upset, nausea, vomiting, diarrhea as well as abnormalities in liver function and renal failure. It may not be suitable for people on oral contraceptives, breast feeding or suffering from hepatic disorders to take rifampicin. These individuals should consult medical professionals for advice.
Rifampicin is classified as antibiotic under the Antibiotics Ordinance and can only be sold on a doctor's prescription and under supervision of a pharmacist.
The spokesman said the department has no record of the product concerned having been imported into Hong Kong for sale. He reminded people who had skin problem to consult medical professionals for appropriate advice or medication if necessary. Members of the public who have been using the product are advised to stop taking them immediately and seek advice from their doctors if necessary.
They should dispose of the product or submit it to the department's Pharmaceutical Service at 3/F, Public Health Laboratory Centre, 382 Nam Cheong Street, Kowloon during office hours.
Reprinted from HKSAR Government web page:
http://www.info.gov.hk/gia/general/200706/12/P200706120176.htm